Operating Lease, Right-of-Use Asset of LENZ Therapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LENZ Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • LENZ Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $847,000, a 45% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LENZ Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $847,000 -$686,000 -45% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $959,000 -$768,000 -44% 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $1,069,000 +$491,000 +85% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $1,338,000 +$1,020,000 +321% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $1,533,000 -$11,662,000 -88% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $1,727,000 -$14,110,000 -89% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $578,000 -$3,436,000 -86% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $318,000 -$5,262,000 -94% 31 Dec 2023 10-K 19 Mar 2025 2024 FY
Q3 2023 $13,195,000 +$6,075,000 +85% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $15,837,000 +$7,201,000 +83% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $4,014,000 -$6,108,000 -60% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $5,580,000 -$5,994,000 -52% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $7,120,000 -$1,957,000 -22% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $8,636,000 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $10,122,000 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $11,574,000 31 Dec 2021 10-K 20 Mar 2023 2022 FY
Q3 2021 $9,077,000 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.